Clinical impact of oncogenic KRASdosage variation in pancreatic cancer. A phase II study of radiotherapy combined with docetaxel, cisplatin, and 5-fluorouracil for postoperative loco-regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results